Topics that will be discussed during CT-Cann2023

  • Phytocannabinoid study – strains, chemovars, entourage and molecules
  • Pharamacokinetics and pharmacodynamics of cannabinoids
  • How can we predict the response to cannabinoid treatment?
  • Clinical cannabinoid therapy across medical specialties such as Pain, Gastroenterology, Palliative Care, Psychiatry and Neurology
  • New and emerging designs for cannabis clinical trials
  • Clinical Registries from around the globe – what can we learn?
  • How to interpret clinical, observational and epidemiological studies: findings, interpretations, applicability
  • Regulatory, licensing, and legal considerations – effects on clinical availability and industry development
  • Cannabinoid trial best conduct including GCP and site training
  • Assessing safety and adverse events of cannabinoid medications
  • National and international guidelines
  • Where is the industry heading? A discussion with leaders in the field
  • Translating Current Evidence to Clinical Practice – meet the expert roundtables, open Q&A and practical tools for prescribers